Moxifloxacin, as an alternative in the treatment of patients with the newly diagnosed pulmonary TB with monoresistance to pirazinamid, or its intolerance

Autor:	Tetiana Sprynsian, Tatiana Butova, Mykhailo Kuzhko, Dmytro Butov, Leonid Grechanyk, Mykola Gumeniuk
Rok vydání:	2021
Předmět:	medicine.medical_specialty Moxifloxacin business.industry Internal medicine medicine Newly diagnosed Pulmonary tb business medicine.drug
Zdroj:	Tuberculosis and non-tuberculous mycobacterial diseases.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::80bdb09a95547e01157b9160e940243f https://doi.org/10.1183/13993003.congress-2021.pa3349 Zobrazit plný text záznamu